UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 8.760

Sortiert nach

A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials

JNCI : Journal of the National Cancer Institute, 2019-12, Vol.111 (12), p.1255-1262

2019

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

Journal of clinical oncology, 2008-02, Vol.26 (4), p.527-534

2008

Link zum Volltext

Verfügbarkeit prüfen

Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations

Journal of clinical oncology, 2014-08, Vol.32 (24), p.2587-2594

2014

Link zum Volltext

Verfügbarkeit prüfen

The quality of clinical trials in neuroendocrine tumours; have we learnt from our mistakes? An evaluation of phase II and phase III clinical trials

Journal of neuroendocrinology, 2021-09, Vol.33 (9), p.e13015-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Trial watch: phase II and phase III attrition rates 2011-2012

Nature reviews. Drug discovery, 2013-08, Vol.12 (8), p.569

2013

Link zum Volltext

Verfügbarkeit prüfen

Antiemetics: American Society of Clinical Oncology Focused Guideline Update

Journal of clinical oncology, 2016-02, Vol.34 (4), p.381-386

2016

Link zum Volltext

Verfügbarkeit prüfen

Reinventing clinical trials

Nature biotechnology, 2012-01, Vol.30 (1), p.41-49

ALLISON, Malorye

2012

Link zum Volltext

Verfügbarkeit prüfen

Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency

Trials, 2014-10, Vol.15 (1), p.383-383, Article 383

2014

Link zum Volltext

Verfügbarkeit prüfen

Empowering phase II clinical trials to reduce phase III failures

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2020-05, Vol.19 (3), p.178-186

De Martini, Daniele

2020

Link zum Volltext

Verfügbarkeit prüfen

Update of the International Consensus on Palliative Radiotherapy Endpoints for Future Clinical Trials in Bone Metastases

International journal of radiation oncology, biology, physics, 2012-04, Vol.82 (5), p.1730-1737

2012

Link zum Volltext

Verfügbarkeit prüfen

Bayesian probability of success for clinical trials using historical data

Statistics in medicine, 2015-01, Vol.34 (2), p.249-264

2015

Link zum Volltext

Verfügbarkeit prüfen

An efficient basket trial design

Statistics in medicine, 2017-05, Vol.36 (10), p.1568-1579

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase I–II clinical trial design: a state-of-the-art paradigm for dose finding

Annals of oncology, 2018-03, Vol.29 (3), p.694-699

2018

Link zum Volltext

Verfügbarkeit prüfen

Optimizing the data combination rule for seamless phase II/III clinical trials

Statistics in medicine, 2015-01, Vol.34 (1), p.39-58

2015

Link zum Volltext

Verfügbarkeit prüfen

A utility‐based Bayesian optimal interval (U‐BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies

Statistics in medicine, 2019-12, Vol.38 (28), p.5299-5316

2019

Link zum Volltext

Verfügbarkeit prüfen

Exclusion of Older Patients From Ongoing Clinical Trials for Hematological Malignancies: An Evaluation of the National Institutes of Health Clinical Trial Registry

The oncologist (Dayton, Ohio), 2014-10, Vol.19 (10), p.1069-1075

2014

Link zum Volltext

Verfügbarkeit prüfen

Methods for proper handling of overrunning and underrunning in phase II designs for oncology trials

Statistics in medicine, 2015-06, Vol.34 (13), p.2128-2137

2015

Link zum Volltext

Verfügbarkeit prüfen

Competing Risks in Older Patients With Cancer: A Systematic Review of Geriatric Oncology Trials

JNCI : Journal of the National Cancer Institute, 2018-08, Vol.110 (8), p.825-830

2018

Link zum Volltext

Verfügbarkeit prüfen

Advances in clinical trial design: Weaving tomorrow's TB treatments

PLoS medicine, 2020-02, Vol.17 (2), p.e1003059-e1003059

2020

Link zum Volltext

Verfügbarkeit prüfen

A flexible mixed-effect negative binomial regression model for detecting unusual increases in MRI lesion counts in individual multiple sclerosis patients

Statistics in medicine, 2015-06, Vol.34 (13), p.2165-2180

2015

Link zum Volltext

Verfügbarkeit prüfen

Confidence intervals for odds ratio from multistage randomized phase II trials

Statistics in medicine, 2024-05, Vol.43 (12), p.2359-2367

2024

Link zum Volltext

Verfügbarkeit prüfen

An adaptive trial design to optimize dose‐schedule regimes with delayed outcomes

Biometrics, 2020-03, Vol.76 (1), p.304-315

2020

Link zum Volltext

Verfügbarkeit prüfen

Optimal adaptive two-stage designs for early phase II clinical trials

Statistics in medicine, 2016-04, Vol.35 (8), p.1257-1266

2016

Link zum Volltext

Verfügbarkeit prüfen

Robust exchangeability designs for early phase clinical trials with multiple strata

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2016-03, Vol.15 (2), p.123-134

2016

Link zum Volltext

Verfügbarkeit prüfen

A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials

Statistics in medicine, 2014-06, Vol.33 (13), p.2206-2221

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 8.760

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.765)
Mit Volltextzugriff
(6.359)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(8.628)
Clinical Trials, Phase Ii As Topic
(7.211)
Science & Technology
(6.793)
Life Sciences & Biomedicine
(6.696)
Oncology
(2.849)
Female
(2.437)
Clinical Trials, Phase Iii As Topic
(2.264)
Clinical Trials, Phase I As Topic
(2.113)
Treatment Outcome
(1.968)
Randomized Controlled Trials As Topic
(1.963)
Male
(1.928)
Clinical Trials
(1.443)
Pharmacology & Pharmacy
(1.437)
Animals
(1.422)
Adult
(1.398)
Middle Aged
(1.379)
Biological And Medical Sciences
(1.371)
Medical Sciences
(1.353)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(1.234)
Antineoplastic Agents - Therapeutic Use
(1.221)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(8.712)
Ingenta
(3.405)
Journals@Ovid Complete
(3.109)
EZB Free E-Journals
(2.980)
IngentaConnect Journals
(1.772)
Publisher website
(1.698)
Elsevier ScienceDirect Journals Complete
(1.488)
SpringerLink (Online service)
(1.146)
Wiley Online Library Journals Frontfile Complete
(1.136)
Taylor & Francis
(892)
Wiley Online Library
(885)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(834)
Taylor & Francis:Master (3349 titles)
(649)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(479)
Oxford Journals
(357)
Nexis Uni
(332)
Nature_系列刊
(297)
Oxford Journals 2020 Medicine
(260)
BMJ_英国医学会期刊
(244)
SAGE Complete
(231)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Statistics In Medicine
(211)
Current Opinion In Investigational Drugs
(207)
Journal Of Clinical Oncology
(197)
Oncology
(146)
Expert Opinion On Investigational Drugs
(141)
Trials
(136)
Seminars In Oncology
(134)
Current Controlled Trials In Cardiovascular Medicine
(130)
Annals Of Oncology
(124)
Bmj Open
(123)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations

The quality of clinical trials in neuroendocrine tumours; have we learnt from our mistakes? An evaluation of phase II and phase III clinical trials

Trial watch: phase II and phase III attrition rates 2011-2012

Antiemetics: American Society of Clinical Oncology Focused Guideline Update

Reinventing clinical trials

Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency

Empowering phase II clinical trials to reduce phase III failures

Update of the International Consensus on Palliative Radiotherapy Endpoints for Future Clinical Trials in Bone Metastases

Bayesian probability of success for clinical trials using historical data

An efficient basket trial design

Phase I–II clinical trial design: a state-of-the-art paradigm for dose finding

Optimizing the data combination rule for seamless phase II/III clinical trials

A utility‐based Bayesian optimal interval (U‐BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies

Exclusion of Older Patients From Ongoing Clinical Trials for Hematological Malignancies: An Evaluation of the National Institutes of Health Clinical Trial Registry

Methods for proper handling of overrunning and underrunning in phase II designs for oncology trials

Competing Risks in Older Patients With Cancer: A Systematic Review of Geriatric Oncology Trials

Advances in clinical trial design: Weaving tomorrow's TB treatments

A flexible mixed-effect negative binomial regression model for detecting unusual increases in MRI lesion counts in individual multiple sclerosis patients

Confidence intervals for odds ratio from multistage randomized phase II trials

An adaptive trial design to optimize dose‐schedule regimes with delayed outcomes

Optimal adaptive two-stage designs for early phase II clinical trials

Robust exchangeability designs for early phase clinical trials with multiple strata

A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials

Suchergebnisse filtern